Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

49.01 -0.98 (-1.97%)
Streaming Delayed Price Updated: 11:08 AM EDT, Jul 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Hims &amp; Hers Health, Inc. (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer &amp; Check, LLP
Via TheNewswire.com
Topics Lawsuit
Contact Levi & Korsinsky by August 25, 2025 Deadline to Join Class Action Against Hims & Hers Health, Inc. (HIMS)
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Contact Levi &amp; Korsinsky by August 25, 2025 Deadline to Join Class Action Against Hims &amp; Hers Health, Inc. (HIMS)
Via TheNewswire.com
Topics Fraud Lawsuit
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
From Pomerantz LLP
Via GlobeNewswire
Multi-Billion Virtual Healthcare Industry Witnessing Substantial Growth with Rapid Expansion Expected
EQNX::TICKER_START (OTCQB:TREIF),(CSE:TRUE),(NYSE:CVS),(NYSE:TDOC),(NASDAQ:TEM),(NYSE:HIMS) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
From SkyMedia, LLC
Via GlobeNewswire
Multi-Billion Virtual Healthcare Industry Witnessing Substantial Growth with Rapid Expansion Expected
From FN Media Group LLC
Via GlobeNewswire
Hims & Hers Announces Plans To Expand Into Canada As Novo Nordisk’s Weight Loss Drug Patent Expires
The telehealth company stated that its entry to Canada will come as generic semaglutide hits the market for the first time. 
Via Stocktwits
Topics Intellectual Property
Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced plans to expand into Canada with a weight-loss solution centered on generic... 
Via StockStory
Topics Artificial Intelligence
What's Going On With Hims & Hers Health Stock Today?
Hims & Hers announced plans to expand its weight loss program to Canada in 2026 in connection with the availability of generic semaglutide anywhere in the world. 
Via Benzinga
Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 25, 2025 - HIMS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Levi &amp; Korsinsky Reminds Hims &amp; Hers Health, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 25, 2025 - HIMS
Via TheNewswire.com
Topics Fraud Lawsuit
Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion
From Hims & Hers
Via Business Wire
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
From Kahn Swick & Foti, LLC
Via GlobeNewswire
Oklo, NuScale, Hims Defy Trump Tariffs - And Power The Russell 2000 Toward New Highs
Small caps outshine tariff fears as Russell 2000 nears all-time highs. Oklo, NuScale, Hims lead with gains of over 95% YTD despite trade turmoil. 
Via Benzinga
Topics Government World Trade
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Hims & Hers Health, Inc. Lawsuit - HIMS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Levi &amp; Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Hims &amp; Hers Health, Inc. Lawsuit - HIMS
Via TheNewswire.com
Topics Fraud Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hims & Hers, Sarepta, and Petco and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
HIMS & HERS HEALTH, INC. (NYSE: HIMS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Hims & Hers Health, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Hims & Hers Navigates Novo Nordisk Breakup And Compounding Lawsuits
Hims & Hers faces stock pressure after Novo Nordisk ends Wegovy access, citing compounding violations and marketing concerns. 
Via Benzinga
HIMS REMINDER: Kessler Topaz Meltzer & Check, LLP Urges HIMS Investors With Losses to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
HIMS REMINDER: Kessler Topaz Meltzer &amp; Check, LLP Urges HIMS Investors With Losses to Contact the Firm
Via TheNewswire.com
Topics Lawsuit
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Seeking Recovery for Investors - Contact Levi & Korsinsky
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Class Action Filed Against Hims &amp; Hers Health, Inc. (HIMS) Seeking Recovery for Investors - Contact Levi &amp; Korsinsky
Via TheNewswire.com
Topics Fraud Lawsuit
Wegovy, Zepbound Prices Drop, But Most Patients Still Can't Afford Long-Term Use: 'Coverage Is Not The Same As Access,' Says Expert
Popular obesity treatments Wegovy and Zepbound are seeing price reductions, but patients still face significant barriers to sustained access. 
Via Benzinga
3 Cash-Heavy Stocks Worth Investigating
A clean balance sheet can signal disciplined management and stability. It also means a company can expand and thrive without relying on borrowed capital. 
Via StockStory
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
From Pomerantz LLP
Via GlobeNewswire
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
From Faruqi & Faruqi LLP
Via GlobeNewswire
Class Action Announcement for Hims & Hers Health, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Hims & Hers Health, Inc.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Fraud Lawsuit
Class Action Announcement for Hims &amp; Hers Health, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Hims &amp; Hers Health, Inc.
Via TheNewswire.com
Topics Fraud Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.